Weight Loss Reduces Physical Disability In Patients With Knee Osteoarthritis

Results from a comprehensive meta-analysis, presented today at the 2006 EULAR congress suggest weight reduction in patients with knee osteoarthritis significantly reduces physical disability and has an impact on pain.



Osteoarthritis is the most common form of joint disease, and it is often associated with significant disability and an impaired quality of life. A number of trials have suggested a relationship between weight loss and clinical benefit in patients diagnosed particularly with knee osteoarthritis, prompting a Danish study team to assess and quantify whether clinical benefits are evident when overweight patients achieve a weight loss.



A total of 23 clinical trials were identified by the study team. Among these, 4 trials met pre-determined inclusion criteria and provided data suitable for further analysis. Three randomized controlled trials (4 intervention/control groups, n=417) reported changes in pain and disability, with 2 trials reporting changes in the Lequesne index, assessing pain, walking and function (n=117).



The association between improvement in physical disability and weight reduction was convincing, and showed that disability reduction could be predicted with great certainty from weight loss.



Whilst the team were not able to predict the clinical efficacy of pain reduction (owing to contradictory results from published trials), meta-regression evidence shows that osteoarthritis patients will experience at least a moderate clinical effect in their physical disability (ES>0.5) with a moderate dietary regime following more than 7.6% weight reduction. In addition, statistical models predicted that even a modest weight loss of more than 5.02% and an intensity of at least 0.25% per week, respectively - would result in a significant disability reduction.



"Based on the pooled analysis from 3 randomised controlled trials, we can provide category 1a evidence that weight reduction does reduce the pain and physical disability in knee OA patients. As such, weight reduction therapy in overweight osteoarthritic patients is a very appealing goal, both with regards to disease specific pain and disability reduction as well as for overall health benefits such as cardiovascular risk reduction" explained study author Robin Christensen, The Parker Institute, HS Frederiksberg Hospital, Copenhagen. "Weight loss is quite possible in these patients in spite of the lack of mobility and physical exercise, often associated with progression of osteoarthritis. A 10% reduction in body weight results in a moderate to large improvement in self reported physical disability; attention from the health care providers is necessary in support of patients learning to cope with a 'double chronic disease' - i.e. both knee osteoarthritis and obesity" he concluded.




















For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress press office on:



Email: eularpressofficeuk.cohnwolfe



Jim Baxter

Jo Spadaccino

Mia Gannedahl



Abstract number: OP0194



About EULAR



* The European League Against Rheumatism (EULAR) is the organization which represents the patient, health professional and scientific societies of rheumatology of all the European nations.



* The aims of EULAR are to reduce the burden of rheumatic diseases on the individual and society and to improve the treatment, prevention and rehabilitation of musculoskeletal diseases. To this end, EULAR fosters excellence in education and research in the field of rheumatology. It promotes the translation of research advances into daily care and fights for the recognition of the needs of people with musculoskeletal diseases by the governing bodies in Europe.



* Diseases of bones and joints, such as rheumatoid arthritis and osteoarthritis cause disability in 4 - 5 % of the adult population and are predicted to rise as people live longer.



* As new treatments emerge and cellular mechanisms are discovered, the 7th Annual European Congress of Rheumatology in Amsterdam (EULAR 2006) brings together more than 10,000 experts - scientists, clinicians, healthcare workers, pharmaceutical companies and patients - to share their knowledge in a global endeavour to challenge the pain and disability caused by musculo-skeletal disorders.



* To find out more information about the activities of EULAR, visit: eular/.



Contact: Mia Gannedahl



European League Against Rheumatism